StonvexLoading…
StonvexStonvexStonvexCore line items from AREN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $20.41M | $134.83M | $106.59M | $76.83M |
Operating Income | $-304.00K | $40.79M | $33.27M | $23.77M |
Net Income | $-2.66M | $124.86M | $119.52M | $112.66M |
EPS (Diluted) | $-0.06 | $2.62 | $2.51 | $2.38 |
Total Assets | $108.25M | $112.60M | $121.36M | $127.78M |
Total Liabilities | $115.67M | $117.43M | $131.58M | $144.94M |
Cash & Equivalents | $11.23M | $10.34M | $12.52M | $6.77M |
Free Cash Flow OCF − CapEx | Not available | $39.25M | $26.13M | $13.97M |
Shares Outstanding | 47.60M | 47.59M | 47.58M | 47.56M |